BEPHARCO ACCOMPANIES THE SCIENTIFIC SYMPOSIUM: “THE ROLE OF NEW ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF SCHIZOPHRENIA AND MOOD DISORDERS”
On August 22, 2025, in Dak Lak, Ben Tre Pharmaceutical Joint Stock Company (Bepharco) was honored to collaborate with Gedeon Richter Vietnam in the scientific symposium titled “The Role of New Antipsychotic Medications in the Treatment of Schizophrenia and Mood Disorders.”
The event brought together leading experts in psychiatry, including:
🔹 Prof. Dr. Cao Tien Duc – Vice President of the Vietnam Psychiatric Association; Rector of Buon Ma Thuot University of Medicine and Pharmacy.
🔹 Dr. Tran Nhu Minh Hang – Department of Psychiatry, Hue University of Medicine and Pharmacy; Mental Health & Psychotherapy Clinic, Hue UMP Hospital; Mental Health Department, Hue Central Hospital.
Notably, the symposium also welcomed:
✅ Directors of Nha Trang Psychiatric Hospital and Dak Lak Psychiatric Hospital, along with department heads, deputy heads, and medical staff from both institutions.
✅ Physicians from Buon Ma Thuot University Medical Hospital and the Dak Lak Provincial Forensic Psychiatry Center.
In a dynamic academic atmosphere, the symposium provided valuable updates, including advances in the treatment of bipolar disorder, the role of third-generation antipsychotics in managing schizophrenia-spectrum disorders, and practical clinical case discussions—offering participants diverse perspectives for improved diagnosis and treatment.









This symposium provided an excellent opportunity for medical professionals to exchange experiences and stay current with the latest advances in the treatment of mental disorders, thereby contributing to improved mental healthcare in Vietnam.
Bepharco is proud to stand alongside esteemed experts and colleagues on the journey to deliver advanced pharmaceutical solutions for a healthier, happier community. We look forward to bringing more meaningful professional programs and events in the near future, continuing to share knowledge and create lasting value for Vietnam’s healthcare and pharmaceutical sector.